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An Analysis of T-Cell Subsets in CNS Plaques 
With Attention to Plaque Borders 
Kimberli E. McCallum 
1986 
Using monoclonal antibodies and an immunoperoxidase 
technique, this laboratory previously demonstrated a 
predominance of the cytotoxic-suppressor T-cell subset in a 
sampling study of plaque and non-plaque areas in C.N.S. 
sections (4). The margin itself was not traversed. Pan T- 
cells (0KT3) and both the cytotoxic-suppressor (C-S) and 
helper-inducer (H-I) subsets were counted in representative 
plaque and non-plaque areas to compare active and inactive 
plaques. Non-plaque areas associated with active plaques 
had fewer C-S cells than areas associated with inactive 
plaques (p < .05). The sum of H-I and C-S cell subsets was 
compared to the number of pan T-cells in both active and 
inactive plaques and in non-plaque areas. C-S cells were 
more numerous than H-I cells or pan-T-cells. 
The present investigation was designed to test the 
hypothesis that T-cells have a special relationship to the 
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borders of MS plaques. This report offers a quantitative 
analysis of the distribution of helper-inducer cells (H-I, 
LEU3A +) and cytotoxic-suppressor cells (C-S, 0KT8 +) in a 
standardized region surrounding the plaque edge (15 
sections, 9 cases). In addition, every field in three 
complete sections from three separate cases was counted (2 
active, 1 inactive by histopathologic criteria). C-S, H-I, 
and pan T-cells were enumerated in each of the border, 
plaque, and non-plaque regions for comparison. 
Graphs generated from the study of the border showed 
that both the cytotoxic-suppressor and the helper-inducer 
subset peaked directly on the edge (p < 0.01). Pan T-cells 
and both subsets were found to cluster at the border region 
in the three whole plaques. Regional variation in the 
relative numbers of T cells was observed. The sum of the 
two T-cell subsets was significantly greater than the 
number of cells bearing the pan T-cell marker in two 
plaques and in two border regions. The C-S:H-I was greater 
in the inactive plaque than in two active plaques. Both 
subsets were concentrated in border regions and in the 
interiors of active plaques with fewer C-S cells in the 
non-plaque regions. 
The present results support a crucial role for T-cell 
subsets in the dynamics of plaque margins. When taken 
together with similar findings in experimental allergic 
encephalomyelitis (EAE), they lead to the tempting thesis 
that helper-inducer cell dominance at the border is 
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necessary for plaque expansion while cytotoxic-suppressor 
dominance in non-plaque areas is associated with controlled 
disease. In addition, they suggest either modulation of the 
0KT3 surface antigen or the presence of non T-cell/0KT8+ 
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Multiple sclerosis is a demyelinating disease 
characterized by discrete plaques scattered throughout the 
C.N.S. Over the last 5-10 years there has been increasing 
evidence that host immune mechanisms play a role in the 
expression and progression of MS. The nature of this 
involvement however has remained elusive. 
Strong evidence for changes in immune function 
associated with MS progression was first presented by Antel 
et. al. in 1978 (2). Con-A activated suppressor cell 
activity was examined in peripheral blood lymphocytes in 
patients with active disease, after flare up, and in those 
with stable disease. The level of supression induced by 
Con-A activated C-S cells on mitogenic responses of 
peripheral blood lymphocytes was reduced in active disease 
(3% +/- 8%) when compared to patients with stable MS (30% 
+/- 8%), patients after flare up (62% +/-5%), and controls 
(40 +/- 5%). In addition, the inhibitory effect of the 
supernatants from these activated C-S cells was reduced 
both in active and stable MS patients when compared to 
controls. 
Subsequent studies showed an association between the 
expression of clinical MS and changes in the ratio of 
peripheral cytotoxic-suppressor (C-S) cells to helper- 
inducer (H-I) cells . Reinherz et. al. (21) used T3 (Pan 
T), T4 (H-I), and T5 (C-S) antibodies to evaluate these 
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subsets in the peripheral blood of 33 patients with 
untreated MS. Their data revealed a reduced percentage of 
T3+ and T5+ cells in active MS. The T4/T5 ratio increased 
from 2-3/1 in normals to 4/1. In a study by Bach et. 
al. (3), T-cell subsets were evaluated in the peripheral 
blood of 47 patients (25 acute phase, 14 remission, 12 
progressive MS). The number of 0KT3 + cells was not 
significantly different in MS patients when compared to 
controls. The percentage of 0KT4+ T-cells was higher in 
patients with acute and progressive MS than in normal 
subjects or those in remission. Other investigators (31) 
showed an increase in the T4:T8 ratio in the majority of 
acute patients tested early in the course of an attack and 
in 25-40% of chronic patients. Compston (7, 8) evaluated T 
cell subsets in the peripheral blood of 36 patients in 
different stages of clinical MS. Patients in relapse had 
lower levels of OKT8 cells when compared to normals (14.07% 
+/- 3.71% vs 29.42 +/-4.69%). No significant differences 
in OKT4 cells are found between the two groups. 
Longitudinal studies of lymphocyte populations in normal 
controls revealed very little variation in the number of 
OKT8 cells within individuals. In contrast, most patients 
with relapsing remitting MS had a reduced number of OKT8 
cells at presentation which returned to normal range within 
one month from the onset of symptoms. In 25 % of the 
patients, abnormalities of lymphocyte populations occurred 
unaccompanied by new symptoms or signs. Studies of spouses 
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and siblings of affected patients revealed concomitant 
abnormalities in peripheral subsets unassociated with 
disease suggesting that environmental factors contributed 
to the susceptibility of these patients. 
Newer techniques for T-cell subset identification 
involving combinations of subset markers may illuminate 
more subtle changes in peripheral T-cell populations 
associated with stages of clinical MS. In a recent report 
(19), patients studied in both stable phase and in acute 
relapse showed no consistent changes in peripheral T-cell 
subsets. Chronic progressive MS was associated with fewer 
LEU2A (C-S) positive cells when compared to stable MS. 
Fluctuations in the number of H-I cells were seen but there 
was no association with clinical activity. 0KT5 cells were 
shown to be a subpopulation of 0KT8 or LEU2A cells. 0KT5 
labelling fluctuated much more than that of the subsuming 
population. Apparent descrepancies in the various studies 
reported may be accounted for by these findings. Other 
investigators (23) have used monoclonal antibodies to the 
T-cell subset markers CD4 (H-I) and CD8 (C-S) in addition 
to the common leukocyte markers Lp220 and Lp95-150 to 
analyze peripheral blood leukocytes in active MS. A high 
frequency of patients with active MS (80%) had a selective 
reduction of the CD+Lp220+ subset compared with controls 
and with patients with inactive MS. The total C-S and H-I 
cell frequencies and the H-I/C-S ratios were not 
significantly different between the patients and controls. 
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Thus, evidence for a selective loss of a fraction of the 
peripheral T-helper cells in active MS has been presented. 
Although the relationship between a drop in peripheral C-S 
cells and acute MS is in doubt, substantial evidence for 
this associated change remains in a proportion of patients 
with chronic-progressive disease. The presence of 
asymptomatic fluctuations in the T-cell subsets in 
peripheral blood is well established. 
Some investigators have studied the pleocytosis of the 
CSF sometimes associated with active MS. Weiner et. al. 
(29) reported that 78% of the CSF cells were T lymphocytes 
with a T4 to T8 ratio of 2:1. No changes in CSF 
phenotypes, however, were related to changes in circulating 
T-cells or disease activity. Hommes et. al. (16) compared 
T-cell subsets in the spinal fluid of untreated MS patients 
to subsets in the CSF of immunosuppressed (oral 
cyclophosphamide / prednisone) chronic-progressive MS 
patients. The percentage of C-S cells out of total cells 
was greater in the treated group than in controls or in the 
untreated group . In addition, the percentage of H-I cells 
out of total cells was lower in the peripheral blood of 
treated patients while the C-S percentage was unchanged. A 
negative correlation was found between the levels of 
intrathecal IgG and the percentage of C-S cells in 
the CSF of untreated patients that was not reflected in the 
peripheral blood. Thus, although T-cell abnormalities of 
the CSF have been shown to be associated with MS, this T- 
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cell population has not been shown to directly reflect 
changes evident in the peripheral blood. 
The studies outlined above suggest that T-cells are 
involved in the pathogenesis of MS. They do not, however, 
describe the pattern of infiltration in the target organ. 
In an immunocytochemical study Esiri et. al. (11) reported 
a qualitative and quantitative analysis of Immunoglobulin 
(Ig) containing cells in C.N.S. sections. Ig containing 
cells were more numerous within plaques than in the 
normally myelinated parenchyma and more numerous in recent 
plaques than in old plaques. Further characterization of 
the inflammatory infiltrate associated with MS, namely the 
distribution of the T-cell subsets, became possible with 
monoclonal antibodies to T-cell subset differentiation 
antigens and better staining techniques for CNS sections. 
In a qualitative study, Traugott et. al. reported 
(27) use of monoclonal antibodies combined with a 
peroxidase-anti-peroxidase (PAP) technique to locate total 
T-cells (Til), H-I cells (T4), C-S cells (T8), and Ia+ 
cells which fit the morphologic criteria for macrophages, 
in frozen sections containing MS plaques with varying 
disease activity. Ia+ cells were most numerous at the 
lesion center and decreased in number towards the edge of 
the lesion in active and in chronic active plaques. In 
active lesions, pan-T-cells, H-I cells, and C-S cells 
displayed a pattern similar to that of the Ia+ cells. 
Virtually no infiltrating cells were found in the normal 
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white matter. In active chronic MS, the numbers of H-I, C- 
S, and pan-T-cells increased from the plaque center to the 
plaque edge. Pan-T cells and and H-I cells penetrated into 
the normal white matter while C-S cells were confined to 
the plaque edge. Sections containing silent chronic 
plaques had fewer T-cells and fewer Ia+ macrophages than 
sections containing active and active chronic lesions. 
Our laboratory reported the first quantitative study 
of T-cell subsets in CNS sections containing MS plaques 
(4). T-cells were counted in seventeen sections from ten 
cases using a sampling technique. Thirty high power fields 
were selected in the same relative white matter location in 
each of the sections stained with the C-S (0KT8) , H-I 
(LEU3A), and Pan T (0KT3) anti-subset markers. Plaque and 
non-plaque areas were enumerated separately. The sites 
chosen for plaques included the center, intermediate zone, 
and demyelinated portion of the margin. Non-plaque areas 
varied in location but avoided overlapping the plaque 
margin. 
Differences between the number of cells bearing 0KT8, 
LEU3A, and 0KT3 markers were examined with a T test for 
dependent paired data. Both T-cell subsets were present in 
the normal appearing parenchyma and in both 
histopathologically active and inactive plaques. T-cells 
bearing the C-S differentiation antigen were found to be 
three times as numerous as those bearing the H-I antigen 





Pan T 1.12 + /- 1.78 0.51 + /- 0.50 
ri-I 0.70 + /- 0.54 0.46 + /- 0.47 
C-S 2.14 + /- 2.32 1.34 + /- 1.32 
H-I/C-S .33 .35 
TABLE 1 
T-cell subsets and ratios in plaque and non-plaque 
areas of 17 C.N.S. sections from 11 cases of M.S. Data is 
recorded as the number of antigen positive cells + /- S.D. 
per high power field (X400). Thirty high power fields were 
counted for each region. 
I 
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was more numerous than the population bearing the pan-T- 
cell marker. The same level of significance was achieved 
for this comparison. Under the same conditions in other 
tissues (spleen, tonsil, and lymph node) appropriate 
equivalence between the sum of the subsets and the number 
of cells bearing the pan-T-marker was noted. 
Active and inactive plaques were compared with respect 
to T-cell populations in plaque and non-plaque regions. As 
shown in table 2, the number of H-I cells was very similar 
in active, or inactive plaques, and in all nonplaque areas. 
The number of C-S cells in plaque areas was also not 
obviously related to the plaque activity. However, in non¬ 
plaque areas associated with active plaques there were 
considerably fewer C-S cells than in non-plaque areas 
associated with inactive plaques. When these data were 
compared with an independent random sample T test for 
unequal variances, the difference was found to be 
significant at p < 0.05. 
Other investigators emphasize the association of S-C 
cell infiltration with MS. In a recent study of over 30 MS 
brains (30) a similar distribution of T-cells in regions of 
perivascular cuffing and in CNS parenchyma with a 
predominance of C-S cells over H-I cells and numerous Ia+ 
macrophages was reported. 
EAE 




6 cases, 6 sections t cases, 11 sections 
Plaque Non-plaque Plaque Non-plaque 
Pan T 1.79 
+ /- 2.45 
0.35 






+ /- 0.49 
0.41 
+ /- 0.55 
0.65 




+ /- 2.69 
0.64 





H-I/C-S 0.35 0.64 0.32 0.28 
TABLE 2 
T-cell subsets and ratios in C.N.S. sections: a 
comparison of active and inactive plaques . Data is 
recorded as the number of antigen positive cells + /- S.D. 
per high power field (X400). Thirty high power fields were 
counted for each region. 
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pathogenesis of MS. Acute experimental allergic 
encephalomyelitis (EAE) is an autoimmune disease that 
develops in susceptible experimental animals sensitized 
with myelin basic protein or spinal cord homogenate and 
complete Freund adjuvant. In the Lewis rat, symptoms are 
transient and self limiting, appearing 10-15 days after 
innoculation and lasting 3-5 days. A chronic relapsing 
disease can be induced in guinea pigs and, under special 
conditions, in rats. The extent to which EAE is a faithful 
model of MS is unclear. However, EAE is an invaluable tool 
for studies characterizing the components of the immune 
system necessary for plaque initiation. The ability to 
predict the appearance of symptoms and monitor changes 
prior to clinical expression of EAE may allow demonstration 
of mechanisms that cannot be evaluated in MS and are 
essential to our understanding of active disease. 
Most reports support a crucial role for T-helper cells 
in acute EAE. In 1960, Paterson et. al. (18) demonstrated 
that EAE could be transferred from sensitized donors to 
naive recipients by cells and not by serum. More recently, 
Hauser et. al. 1984 (12) showed that thymectomized 
irradiated mice reconstituted with Lyt 1 (H-I), Lyt 2 (C- 
S), or Lyt 1 + Lyt 2 developed EAE after reconstitution 
with Lyt 1 or Lyt 1 + Lyt 2 cells and not consistently with 
Lyt 2 cells alone. Thus, Lyt 1 cells (H-I) are necessary 
and sufficient for restoring susceptibility to EAE in mice. 
Others showed that pre-treatment of sensitized lymphocytes 
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with monoclonal antibodies against the H-I subset blocked 
passive transfer of clinical EAE in rats (26). These data 
are corroborated by reports of the treatment of acute EAE. 
Brostoff and Mason (5) injected W3/25, a monoclonal 
antibody recognizing rat T-helper cells into Lewis rats 12 
to 13 days after induction. The antibody was not cytotoxic 
but reduced the intensity of labelling on the target cells. 
This treatment lead to an early recovery not accomplished 
with anti-pan-T-cell antibody. No qualitative histologic 
changes were noted after this treatment and recovery. 
Waldor et. al. (28) prevented the development of EAE and 
reversed the symptoms of mild EAE with early administration 
of the monoclonal antibody GK1.5 directed against the 
murine helper-inducer marker L3T4. In these studies, a 
reduction of L3T4 cells was demonstatrated in the spleen 
and lymph nodes. In addition, fewer perivascular 
infiltrates in the brains of treated animals were 
demonstrated. No evidence for alterations in T-cell subset 
balance in CNS sections associated with treatment using 
monoclonal antibodies against the H-I subset in EAE has 
been reported to date. 
Immunohistopathologic studies do, however, confirm the 
predominant role of the helper subset. Hickey et. al. 
(15) used monoclonal antibodies in a quantitative study of 
cellular infiltration in the spinal cord of Lewis rats 
during acute EAE. They found that the infiltrates were 
predominately W3/25 cell type. 
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The influx of cells into the CNS compartment may be 
reflected in the peripheral blood in EAE. Hauser et. al. 
(13) demonstrated that the percentage of lyt 1 cells (H-I) 
cells in the peripheral blood was transiently reduced 
during the immediate pre-symptomatic phase of EAE . 
Immunohistochemical analysis of CNS infiltrates revealed 
that the earliest lesions consisted of predominately Lyt 
1+2- lymphocytes. Hickey et. al. (14) attempted to 
distinguish between pathologic changes in the chronic 
relapsing disease and the acute self-limited form. They 
found that the major differences between the T-lymphocyte 
populations in acute EAE compared to the asymptomatic 
condition were an increase in the 0X8 (C-S) T-cells and a 
diffuse scattering of lymphocytes in the CNS in the 
asymptomatic states. Taken together, the EAE studies 
demonstrate a requirement for H-I T-cells for disease 
induction and an association of C-S T-cells with 
inactivity. 
Hypothesis 
The above studies have attempted to describe the 
inflammatory changes present in the peripheral blood, CSF, 
and CNS associated with clinical MS and EAE. Most 
histopathologic reports have discussed general changes in 
the infiltration of the CNS parenchyma or in perivascular 
regions. As the plaque edge may be the locus for immune 
interactions which control lesion progression, subset 
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distribution in this defined area may shed light on the 
mechanisms which lead to plaque progression or hold plaques 
in check. This thesis provides the first quantitative 
analysis of T-cell subsets in the region surrounding the 
plaque edge. If T-cells are involved in the pathogenesis 
of MS they must have a role at the plaque edge. 
My hypothesis is that T-cells are not randomly 
distributed in the CNS but, instead, have a special 
relationship to the plaque border. I have examined the 
distribution of T-cell subsets about the plaque edge, 
differences in this distribution associated with plaque 
activity, and the predicted verses the observed 
distribution of cells bearing the pan-T-cell marker in the 
CNS. I hope that these findings will contribute to our 
understanding of the pathogensis of MS and thus provide 




MATERIALS AND METHODS 
Tissue Preparation and Staining Methods 
As previously reported, material for study was 
obtained from the UK and from the National Neurologic 
Specimen Bank in the United States.(4) For the present 
study, CNS material from 10 cases (17 sections) were 
studied. Tissues from the UK were processed fresh while 
tissues from the National Neurological Specimen's Bank were 
received frozen. Sections were cut with a cryostat (-20 
degrees Celsius) at 10-12 urn thickness, mounted on gelatin 
coated slides, and fixed in acetone for ten minutes. All 
sections were brought to room temperature and washed with 
TRIS buffer (pH 7.4) and were treated with monoclonal 
antibodies diluted 1:5 or 1:10 in TRIS buffer. Serial 
sections were treated with LEU3A antibodies (Becton 
Dickson) against helper-inducer subset antigen, OKT8 
antibodies (Ortho Diagnostics) against the cytotoxic 
suppressor subset antigen, and OKT3 antibodies against the 
pan T-cell antigen (Ortho Diagnostics). After incubation 
for 45 minutes in a humidified atmosphere , the sections 
were washed and exposed to peroxidase conjugated rabbit 
antibody against mouse immunoglobulin (Dako) for thirty 
minutes and washed again before treatment with 
diaminobenzidine (60 mg/100 ml in TRIS buffer) with one 
drop of H202 for five minutes. Sections were then washed in 
water, lightly counterstained with heamatoxylin blue. 
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dehydrated, cleared, and mounted. (Figure 1A & B) Separate 
sections from each block were also stained with a modified 
hematoxylin stain and Oil Red 0 so that the activity of the 
plaque could be accessed. The heamatoxylin stain 
demonstrated the boundary and the cellularity of the lesion 
whereas the Oil Red 0 stained phagocytic cells laden with 
the products of myelin breakdown. Stained specimens were 
scanned at intermediate power so that the exact edge could 
be marked. 
Method of Counting of the Border Region 
Sections were selected for determination of the 
distribution of the T-cell subsets in an area surrounding 
the border of a typical MS plaque. Fifteen sections from 
nine cases were suitable for this method. The borders of 
plaques stained with the LEU3A and 0KT8 markers were 
carefully defined by comparing them to the sections stained 
with modified heamatoxylin. A glass piece with square grids 
was fitted into the eyepiece of the microscope to 
facilitate counting. Cells positively stained with each 
antibody were counted in square grids that were each 
circumscribed by one high power field (X400). Data was 
recorded as the number of positively stained cells within a 
high power field grid. One field was centered on the 
border and the number of positive cells was recorded. 
Three fields into and three fields away from the plaque 




These color photographs were reproduced from 
transparencies. They demonstrate immunoperoxidase staining 
in spinal cord sections. Each is lightly counterstained 
with heamatoxylin blue. 
A. LEU3A+ stained cells in the parenchyma near the 
plaque edge. 250X magnification. 
B. 0KT8+ stained cells in the parenchyma surrounding 
two perivascular regions. 250X magnification. 
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first border field, was then centered on the border and the 
counting process into and away from the plaque was 
performed. This was repeated up to six times to produce a 
series of seven field vectors for each plaque studied 
(Figure 2A and B). Equivalent areas of the border were 
tabulated for each of the two antibodies. To estimate the 
number of positive cells at each of the seven distance 
fields we had to first take into account large differences 
due to the variable number of positive cells in a section. 
This regression problem was soluble with Generalized Linear 
Integrative Modelling (GLIM). GLIM is a program designed 
to address non-orthogonal multiple regression problems 
(3.12<C> 1977 Royal Society, London). Because the average 
number of T-cells per field was low, the distribution was 
assumed to be poisson and corrections were made for 
deviations. 
Estimation of Histopathological Activity 
It seemed possible that the distribution of T cell 
subsets about the border would vary with the 
histopathologic activity. This was scored on the basis of 
three criteria: the presence of macrophages, degree of 
cellularity, and the presence of Oil Red 0 phagocytosed 
material. Eight border regions were inactive (score=l), 
four showed some signs of activity (score=2), and three 
were considered to be active (score=3) in the border study. 















Techniques for the quantitative evaluation of plaque 
borders. 
A. Schematic diagram of a M.S. plaque in a typical 
C.N.S. section (spinal cord). 
B. Close up of the plaque edge: technique for the 
border study. One square field grid is centered on the 
plaque edge and 6 flanking fields were counted. This 
process was repeated several times along various sections 
of the plaque edge. 
C. Close up of the plaque edge: technique for counting 
3 whole plaques. Every field in the section is counted and 
recorded in a grid. The plaque edge is projected onto the 




plaque regions preceeding this work , it was not possible 
to score activity as precisely because the larger regions 
encompassed were not uniform with respect to 
histopathologic activity. Therefore, only the predominance 
of activity or inactivity was considered. Six sections 
were considered active and eleven inactive. 
Counting of Whole Sections 
Three plaques from three different cases were selected 
in which the staining and the tissue presentation of 
comparable sections stained with the 0KT8, LEU3A, and 0KT3 
T-cell markers were uniform throughout the sections. The 
number of positive cells were tabulated for every field in 
the sections. This resulted in three data maps for each 
section composed of squares of equal size recording the 
number of positive cells found in each field. The border 
lines of the plaques were drawn by projection. Fields that 
were transected by a plaque edge as well as the adjacent 
whole fields were counted as "border area". The remaining 
fields were counted as plaque or non-plaque areas (Figure 
2A and C). All fields in each area were added together and 





T-cell Subsets on the Border 
Scanning the sections under low power, it was noted 
that the number of immunoperoxidase positive cells varied 
greatly among the sections. While many sections had only a 
few positive cells, one had up to twenty-five positive 
cells in a high power field grid. Lymphocytes and 
macrophages were abundant in perivascular and vessel 
associated areas in many sections (Figure IB). In some 
plaques there appeared to be a gradient of cells from the 
vessel decreasing outward and leading towards the border. 
Within each section, cells were clustered on the border. A 
summary of the tallies obtained in collecting the data is 
provided in appendix A. To quantify the number of cells 
with respect to the distance from the border it was 
necessary to consider the variability of the number of 
positive cells in each section. Computer estimates for the 
mean number of T-cells of both subsets in each distance 
field were derived using the GLIM program and are shown in 
Figure 3. These estimates include both active and inactive 
plaques. Although some plaques had many positive cells, 
the average was less than two cells per high power field. 
Both subsets peaked on the exact border and the number of 
cells fell off to lower values on either side. LEU3A cells 
immediately inside the plaque edge fell off more quickly 
than in the parenchyma immediately outside of the plaque 
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Field Grid Number 
FIGURE 3 
The distribution of subsets across the plaque edge. 
The vertical axis represents the number of cells per high 
power field grid estimated at each distance field using 
linear regression (GLIM). LEU3A cells are not distributed 
randomly across plaque borders (p <0.001) nor are OKT8 
cells distributed randomly across plaque borders (p < 
.001). OKT8 positive cells and LEU3A positive cells are 
more numerous in fields centered on the exact edge than in 




edge. There was a highly significant difference in the 
number of cells among distance fields across the border. 
(p < .001 for both OKT8 and LEU3A). OKT8 positive cells 
and LEU3A positive cells are more numerous in fields 
centered on the exact edge than in the flanking border 
fields, (p < .05 for C-S and p < .025 for LEU3A) On the 
whole, the cytotoxic-suppressor cells predominated. The C- 
S:H-I ratio was greatest in flanking fields within the 
plaque where it was 3:1. The raw data are included in 
appendix A. 
Analysis by Histopathologic Activity 
Since some studies have reported a reduction in the 
number of circulating cytotoxic-suppressor T-cells 
associated with MS activity (3,7,31), we were interested in 
any association between histopathologic activity and the 
distribution of T-cell subsets in the CNS. 
By definition, there tended to be more cells in the 
border fields of active plaques. There were too few 
histopathologically active plaques, however, to reliably 
determine the effect of this factor in the border area 
studies. Further, activity was confounded with the 
variability in the number of cells in sections between 
individuals. One of the most active plaques had many more 
H-I than C-S cells as well as more positively staining 
cells overall. This ,however, was the only plaque in the 
border study in which the H-I subset predominated. 
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Counts of Complete Sections 
All previous studies of T-cell subsets in M.S. 
iesions have used qualitative methods or used sampling 
techniques for quantitation. I have used a vector method of 
sampling the border region in the border study described 
above. In this study , by broadly defining a border area, 
we were able to compare the edge to fields beyond the six 
field grids flanking the edge. In addition, the technique 
of considering the border separately was applied in order 
to reveal the absolute distribution of T-cell subsets in 
three whole sections. The method of counting is shown in 
Figure 2C. The raw data is tabulated in appendix B. 
Figure 4 compares the number of C-S cells to the 
number of H-I cells per high power field grid of three 
plaques. Sections La 34 and La 25 are active and section 
La 29 is inactive. The plaque edge includes the border 
field and two flanking fields (compare figure 2B & 2C). 
The plaque area showed a relative clustering of T-cell 
subsets. The average number of C-S cells per high power 
field was greater in the plaque than in the non-plaque 
areas in all three sections. LA 29, the inactive plaque, 
had the greatest number of C-S cells and the greatest ratio 
of C-S to H-I cells in all three regions. Furthermore, the 
numbers of C-S and H-I T-cells in LA 34, an active plaque, 
were nearly equal. 
The average number of pan-T-cells has been found to be 






























LA 34 LA 25 LA 29 
Activity-3 Activity* 3 Activity-1 
FIGURE 4 
The comparison of T-cell subsets in 3 whole plaques. 
KEY: /:::/ = H-I or LEU3A , / / = C-S or OKT8 
Activity 3 = active; Activity 1 = inactive 
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non-plaque regions (table 1). The pan T-cells as well as 
the T-cell subsets were therefore counted in the three 
whole sections with particular interest in any association 
of this discrepency with the plaque border. Figure 4 
compares the sum of the C-S and H-I T-cells to the number 
of cells bearing the pan T-cell marker in plaque, non¬ 
plaque, and in border areas. The sum of the subsets is 
greater than the number of pan T-cells in two plaque and in 
two border regions. The section (LA 34) with significant 
discrepencies in two regions is active. It has the 
greatest proportion of the H-I subset with a few more H-I 




A comparison of the sum of the subsets to the number 
of pan T-cells in 3 whole plaques. 0KT8 + LEU3A > 0KT3 in 2 
border regions and in two plaque regions. 
Key: /:::/ = H-I, / / = C-S, /###/ = Pan T-cell (0KT3) 




Multiple sclerosis has a characteristic pathology 
marked by focal periaxial demyelination. Cases usually 
come to necropsy in the chronic stages of illness, death 
often occurring because of a secondary infection. 
Therefore, plagues of varying age will be observed 
throughout the white matter of the individual. Little is 
known of the initial stages of plague expansion as we lack 
a sufficient amount of pathological material taken at the 
onset of clinical disease or relapse. Classically, lesions 
are thought to begin with structural changes in the myelin 
sheath and macrophage proliferation. Shortly thereafter, 
astrocytes appear to be reactive and microglia become 
phagocytic and may harbor products of myelin breakdown . 
Myelin staining reveals a clearly defined edge. 
Macrophages and astrocytes are more numerous throughout 
plagues; oligodendrocytes are less numerous. The greatest 
increase in cellularity has been associated with the edge 
of the lesion. The plaque edge, the interface between 
plaque and normal myelin, is the immunologic environment in 
which plaque expansion occurs. 
Several investigators have previously studied 
lymphocytes associated with MS plaques. Plasma cells have 
been demonstrated to be associated with the edge of active 
plaques (11). In addition, areas of lymphocytic cuffing 
associated with small vessels in and around plaques have 
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been shown to contain many T lymphocytes (11,30). Traugott 
(27) found H-I and C-S cells increased in numbers from the 
center to the edge of active chronic lesions and H-I cells 
penetrated into the normal parenchyma. This laboratory has 
previously demonstrated a predominance of C-S cells 
throughout sections containing MS plaques. Weiner et. al. 
(29) also noted an over-representation of C-S cells 
compared to H-I cells in the cellular infiltration of the 
parenchyma as well as in regions of perivascular cuffing. 
The present studies were designed to evaluate the 
distribution of T-cell subsets about plaque borders. 
I have found that both the C-S and the H-I subsets 
peaked on the exact border. However, the C-S and H-I 
distribution curves formed different patterns across the 
border . The slope of the H-I cell profile drops off more 
quickly inside the plaque than in normal parenchyma so that 
one field into the plaque is likely to have fewer cells 
than one field immediately adjacent to the edge in the 
myelinated parenchyma. In contrast , the number of C-S 
cells in fields immediately adjacent to the edge are nearly 
equivalent on either side of the border field. The 
relative balance of H-I to S-C inside the plaque edge is 
therefore different from the balance in fields adjacent to 
the plaque edge in the myelinated parenchyma . The C-S 
subset was more numerous than the H-I subset immediately 
inside the plaque but the two subsets were nearly 
equivalent in adjacent myelinated parenchyma. At distances 
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further from the edge fewer cells of either subset are 
present. With the exception of fields centering on vessels 
that exhibit lymphocytic cuffing, no fields have more cells 
of either subset than those associated with the exact edge 
of demyelination. The apparent local difference in the 
immune balance associated with the border of demyelination 
is difficult to interpret. It describes a non-uniform 
relationship between subsets and invokes the notion of 
opposing active roles for the two types of cells rather 
than one of a uniform effector response. 
The domain of the plaque interior is immunologically 
different from that of the plaque exterior. In the 
sampling study, C-S cells were more numerous inside active 
plaques than in the surrounding normal parenchyma. In the 
study of three whole plaques including 2 active and 1 
inactive plaque, C-S cells were more numerous in plaques 
and in the border region than in normal parenchyma. It 
appears that C-S cells are concentrated in border regions 
and in the interiors of active plaques but are more 
uniformly distributed in inactive plaques. Mature B cells 
may be distributed similarly. Esiri found that Ig 
containing cells were more numerous within plaques than in 
the surrounding parenchyma and more common in active 
plaques than in inactive plaques (11). On closer 
examination, plaque sampling reveals a non-significant 
predominance of H-I cells within plaques over those in the 
surrounding parenchyma which is again stronger in active 
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plaques. Taken together these findings reveal an 
association of plasma cells, C-S cells, and possibly H-I 
cells with plaque interiors and suggest that a stimulus for 
immune cell proliferation resides within active plaques or 
in the border region. As the plaque can be thought of as a 
sum of aging borders, the association of these cells with 
the borders is of particular interest. 
The average number of T-cells per plaque is small and 
varies greatly. In the CNS of patients with no known CNS 
disease, the average number of LEU3A cells was .13 while 
the average number of OKT8 cells was .26 in each field 
(4). The number of C-S and H-I cells on the exact border 
of all MS plaques (inactive and active) that were studied 
was in the range of 1 to 2 cells. Many factors might 
effect the numbers of T cells including plaque activity, 
present or past therapies, and the proximity of the plaque 
to vessels. It is not clear whether only a few T cells 
need to be involved in the process or whether large numbers 
of T-cells are present for a brief period of time not 
adequately described by these data. The small absolute 
number of cells might reflect a regulatory rather than 
effector role for these lymphocytes in a scenario in which 
active demyelination is achieved by other cells or factors. 
I suspect that present methods for identifying active 
plaques confound the data and obscure possible 
interpretations. Ideally , the criteria used to identify 
active plaques would divide plaques into dynamic stages of 
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initiation, expansion, and stabilization. Plaque oil red o 
positivity is a relatively late change reflecting myelin 
breakdown and phagocytosis. Macrophages and 
hypercellularity which are markers of inflammation appear 
early but persist. Glial scarring and hypocellularity are 
markers of inactivity. Unfortunately, the present criteria 
cannot reliably characterize a particular plaque as 
belonging to one of these three dynamic phases. In 
addition, no link between markers of activity and clinical 
expression of MS has been established. Therefore, 
comparison of T cell patterns with stages of activity 
defined by present histopathologic criteria is problematic 
and formulation of any dynamic model must be tentative. 
With the above limitations in mind, our data 
nevertheless suggests that changes in the ratio of T cell 
subsets may correspond to changes in plaque activity. In 
our previous studies, plaque sampling revealed that the 
number of H-I cells was very similar in white matter 
surrounding both active and inactive plaques. However, in 
the non-plaque areas associated with active plaques there 
were fewer C-S cells than in non-plaque areas associated 
with inactive plaques. The increased number of C-S cells 
in non-plaque white matter associated with inactive plaques 
was significant at p < 0.015. The border study sampled the 
seven border fields in a set of predominantly inactive 
plaques and revealed a C-S dominance at the border. H-I 
cells outnumbered the C-S cells in one active plaque. 
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Several other active plaques had nearly equal numbers of 
the two subsets including the two active plaques in the 
whole plaque study . These findings, while not 
statistically significant, when taken together with the 
statistically significant sampling study, lead to the 
tempting thesis that lesion progression in MS is associated 
with H-I T-cells, while stabilization is associated with 
C-S T-cells. 
This thesis is strengthened by similar observations in 
EAE. CNS infiltration by macrophages and T cells (15,25) 
in early lesions in mice are associated with predominately 
Lyt-1 (H-I) lymphocytes (13). Hauser et al. (12) showed 
that mice depleted of their T-cells could be immunized to 
regularly develop EAE only after reconstitution with cells 
bearing the H-I (LYT-1) marker. Brostoff and Mason (1984) 
demonstrated that monoclonal antibody directed against rat 
helper T-cells reduced the duration of symptoms in rats 
treated after the appearance of clinical signs (5). In 
contrast, Hickey et. al. showed a persistence of 0X8 cells 
(C-S) associated with the symptom free stage in rats 
(14,15) . 
There is evidence for a correlation between T cell 
ratios and the expression of other immune linked disease. 
Typical normal tissue ratios are not well worked out for 
each subset. In absence of disease, few T cells are present 
at all. Regional differences in the predominating cell 
type have been documented in chronic liver disease. C-S 
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cells were found to be more numerous in areas of piecemeal 
necrosis while cells bearing the pan-T-cell marker 
predominate in portal areas without piecemeal necrosis 
(24). Colucci et. al. (6) have described a predominance of 
C-S cells in chronic active hepatitis and H-I cells in 
chronic persistent hepatitis. In graft vs host disease, 
HI:CS ratio is 1:10 while in rheumatoid arthritis , HI:CS 
tissue ratios range from 5 to 15 : 1 (17). In chronic 
progressive MS, we found this ratio is 1:3 (4). 
The previous finding that C-S cells outnumber pan-T- 
cells in sampled plaque and non-plaque regions (4) was 
unexpected. An attempt was made to eliminate the 
possibility that the predominance was due to errors in 
technique by the use of controls. Under the same 
conditions in other tissues it was found that there was an 
approximate equivalence between the sum of the subsets and 
the number of cells bearing the pan-T-marker. In addition, 
use of the anti SRBC receptor reagent T11A did not alter 
the discrepancy. Oligodendrocytes did not stain with C-S 
antibody in control tissues to account for the apparent 
excess of C-S cells compared to the pan-T-cells. In the 
present study of three whole plaques , subsets summed to 
equal pan-T-cells in some areas suggesting that the 
discrepancy was non-uniform. Interestingly , in this small 
sample , only plaque and border areas had fewer than 
expected cells bearing the pan-T-cell marker. This 
suggests that the expression of the pan-T-cell marker may 
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be effected by the disease process. The quantitative 
analysis of more border regions is required before this 
finding can be interpreted in the context of all MS 
plaques. 
It is tempting to attribute the observation that the 
C-S cells are more numerous than the cells bearing the pan- 
T-marker to antigenic modulation. It is reasonable to 
postulate a decrease in the expression of the pan-T-cell 
marker in certain cytotoxic-suppressor cells. If 
modulation is present, its role in the pathogenesis of MS 
is intriguing. Modulation is known to be present in some 
immunodeficiency states. The lymphoid cells of most 
patients with combined immunodeficiency lack surface 
expression of T3 (22) . It has been shown that T3 
modulation by anti-T3 antibody has no effect on T-cell 
viability but decreases cytotoxic effector function of T4 
and T8 clones for up to 48 hrs. In addition, the 
proliferative response to IL2 was greater in these cells 
(1). It appears that altered antigen recognition and 
disturbed T-cell function are associated with T3 
modulation. The findings of the present study suggest that 
T3 modulation may be present in areas of demyelination 
supporting a theory of altered T-cell function in MS. 
Another paradigm, the presence of a T8 bearing non T- 
cell population, might explain the presence of 0KT8 
positive, 0KT3 negative cells. For example, Hepatitis B has 
several correlates to MS both in the active/chronic nature 
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of the disease and in the patterns of tissue infiltration 
by inflammatory cells. Colucci reported that the sum of 
the subsets outnumbered the pan-T-cells in 5 out of 26 
cases of chronic active hepatitis (6). In acute hepatitis, 
Eggink et al found LEU7 + (NK cells) and 0KT8+,0KT1-,0KT3- 
cells predominated over 0KT8+,0KT1+,0KT3+ cells (9). In 
contrast. Chronic hepatitis B sections had a predominance 
of 0KT8+,0KT1+, 0KT3+ cells (10). Clearly, further studies 
are required to determine if the cells bearing OKT8 but not 
OKT3 antigen are natural killer (NK) cells. 
In human immature "common" thymocytes, OKT4 and OKT8 
antigens and not OKT3 antigens are associated with the 
surfaces of cells. Mature thymocytes acquire OKT3 
reactivity and segregate into OKT4 or OKT8 subsets prior 
to exportation into the peripheral compartment (20). Most 
evidence supports the notion that the CNS lymphocytes 
associated with MS reached their destination via the blood. 
It is possible, however, that these OKT3- lymphocytes 
represent immature cells derived from stem cells native to 
the CNS. Interactions with soluble factors and macrophages 
might then provide an alternative explanation for the 
observation that these lymphocytes appear to cluster in 
perivascular regions. 
A goal in the investigation of immune cell involvement 
in the pathogenesis of MS is to uncover patterns which 
would suggest a rational approach towards therapeutic 
intervention. Since T-cells cluster in perivascular 
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regions and are present within these vessels, it is 
generally assumed that blood borne lymphocytes have access 
to the CNS in MS. Peripheral forms of immunotherapy 
therefore seem possible. Immunotherapy might focus on the 
H-I/C-S balance. The function of the C-S cells remains 
unknown but it is critical to clarify the significance of 
C-S dominance. If C-S cells have a suppressor function, 
the theory that C-S cells hold plague progression in check 
would be supported. Immunotherapy could then be tailored 
to increase suppression or decrease help. If, these cells 
were instead primarily cytotoxic, we might attempt to 
decrease cytotoxic activity. The histopathologic findings 
in MS might suggest both a time and target for specific 
immunotherapy. A clear dynamic paradigm based on further 
studies of the functional roles of immune cell subsets in 
the C.N.S. is needed before a safe rational approach 




A: Border Study Data 
The data obtained in the border study is provided 
below. It was not possible to count the same number of 
fields in each section because of variations in the size, 
shape, and staining of plaques. Analysis required the 
Generalized Linear Integrative Modelling program mentioned 
earlier in this thesis. The distribution of the number of 
cells per one high power field best fits the poisson 
distribution. Deviation from the expected distribution 
were noted and the appropriate transformations were 
performed before analysis. Estimates for each of the 
increasing distance regions were plotted in figure 3. 
Key: Sections are named and numbered if part of a series 
from one case: eg. LA, UKA, UKB, UKC . Activity 
is ranked from least active to most active, 1 to 3. 
Distance fields are recorded in three fields into the 
plaque and three fields into the normal parenchyma with 
one field centered on the plaque edge as a reference point. 
Negative numbers represent fields inside the plaque while 
positive numbers represent fields in the myelinated 
parenchyma. This process was repeated "n" times. Totals 
devided by "n" would represent the average number of cells/ 








LA #4 Activity 1 
distance -3 -2 -1 0 1 2 3 
0KT8 
total 11 12 17 12 1 5 5 
n 5 5 5 5 5 5 4 
average # of cells on border: 2.4 
LEU3A 
total 3 3 2 8 1 4 0 
n 2 3 4 4 4 4 1 
average # of cells on border: 2 
LA # 29 Activity 1 
distance -3 -2 -1 0 1 2 3 
0KT8 
total 4 b 2 b 2 3 4 
n 6 6 6 6 6 6 6 
average # of cells on border: .83 
LEU3A 
total 0 0 0 0 2 0 0 
n 4 4 4 4 4 4 4 
average # of cells on border: 0 
LA # 25 Activity 3 
distance -3 -2 -1 0 1 2 3 
0KT8 
total 4 7 9 9 5 0 0 
n 10 10 10 10 10 10 10 
average # of cells on border: . 9 
LEU3A 
total 2 0 0 2 0 0 0 
n 4 4 4 4 4 4 4 
average # of cells on border: . 5 
LA # 27 Activity 2 
distance -3 -2 -1 0 1 2 3 
OKT8 
total 13 14 9 12 1 2 1 
n 4 4 4 4 4 4 4 
average # of cells on border: 3 
LEU3A 
total 0 0 3 4 0 0 1 
n 4 4 4 4 4 4 4 
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average # of cells on border: 1 
5. LA #35 Activity 2 
distance -3-2-1 0 1 2 
0KT8 
total 5 13 16 8 4 
n 2 5 5 4 4 
average # of cells on border: 3.2 
LEU3A 
total 2 6 5 4 3 
n 3 3 3 3 3 
average # of cells on border: 1.7 





average # of 
NO LEU3A 
-3 -2 -1 0 
3 9 4 9 
5 5 5 5 





7. UKA Activity 1 
0KT8 
distance -3 -2 -1 0 1 2 
total 3 2 0 1 1 0 
n 5 5 5 5 5 5 
NO LEU3A 
average # of cells on border: .2 
8. UKB #1 Activity 1 
0KT8 
distance -3 -2 -1 0 1 2 
total 4 0 2 5 10 6 
n 4 5 6 6 6 6 
NO LEU3A 
average # of cells on border: .83 
9. UKB #2 Activity 1 




















10. UKB #3 
OKT8 
LEU3A 
11. UKC #1 
OKT8 
LEU3A 
12. UKC #2 
OKT8 
LEU3A 
total 2 6 11 13 10 7 4 
n 1222221 
average # of cells on border: 6.5 
.ctivity 1 
distance -3-2-1 0 1 2 3 
total 0011044 
n 4555554 
average # of cells on border: .2 
total 0010113 
n 4444433 
average # of cells on border: 0 
Activity 1 
distance -3-2-1 0 1 2 3 
total 9 6 5 16 11 8 6 
n 6666664 
average # of cells on border: 2.7 
total 9 2 1 8 5 17 
n 3 3 3 3 3 3 
average # of cells on border: 2. 
Activity 2 
distance -3-2-1 0 1 2 
total 315638 
n 5 5 6 5 5 5 
average # of cells on border: 1.2 
total 0 2 0 0 1 3 3 
n 3333333 
average # of cells on border: 0 























-3 -2-1 0 1 
0 2 5 10 6 
3 5 5 5 5 
# of cells on border: 
0 0 3 2 5 
5 5 5 5 5 










14. UKC #4 & 5 This plaque is the fusion of two smaller 
plaques. Both sections were sampled and included in the 
following talley. Activity 3 
distance -3-2-1 0 1 2 3 
OKT8 
total 13 39 54 24 17 
n 9 9 9 9 9 
average # of cells on border: 6 
LEU3A 
total 6 13 15 89 59 35 17 
n 4677775 
average # of cells on border: 12 
15. UKC #6 Activity 2 
distance -3-2-1 0 1 2 3 
OKT8 
total 13 9 9 20 12 7 4 
n 6666653 
average # of cells on border: 3.3 
NO LEU3A 
B: Study of Three Complete sections 
The following data is graphed in figures 4 and 5. 
Both the vessel associated and nonvessel associated numbers 
are tabulated below although only totals appear on the 
included graphs. Data is recorded as the average number of 
cells per field. The n values (number of counted high 
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power fields) are in parentheses . Key: NVA = non vessel 
associated fields. Total = cells in parenchyma in NVA 
fields in addition to those associated with vessels . 
Methods of determining plaque , nonplaque, and edge regions 
have been described in methods section. 
CASE 34 25 29 
PLAQUE 
NVA 
0KT8 .43(109) .28(306) 1.25(64) 
LEU3A .33(111) . 12(202) .25(68) 
0KT3 .35(227) .79(71) 
TOTAL 
0KT8 .55(117) .43(325) 1.36(67) 
LEU3A .41(118 ) . 24 ( 231) .32(73) 
0KT3 .50(68) .70(254) 1.1(82) 
NON-PLAQUE 
NVA 
0KT8 .37(59) .14(216) .74(219) 
LEU3A .42(67) .036(222) .24(233) 
0KT3 .88(42) .31(153) 1.1(206) 
TOTAL 
0KT8 .42(62) .19(220) . 94 ( 235) 
LEU3A .47(70) .05(226) .31(245) 
0KT3 .88(42) .39(156) 1.3(228) 
EDGE 
NVA 
0KT8 .65(270) . 56(110) 1.8(120) 
LEU3A .56(252) .41(104) .39(126) 
0KT3 .98(234) .52(129) 2.2(129) 
TOTAL 
0KT8 .79(283) .85(124) 2.0(136) 
LEU3A .83(256) . 52(108 ) . 46(136) 
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